News

News

Retired NFL Quarterback Vinny Testaverde Endorses NanoVibronix's SPORT Painshield(TM)

2 August, 2016

NanoVibronix, Inc, (OTCQB: NAOV), a medical device company, announced today that Vinny Testaverde, retired quarterback who played 21 seasons in the NFL and Heisman trophy winner, has endorsed NanoVibronix's SPORT Painshield™ for relief of joint and back pain.

Like many retired sports players, Vinny suffered chronic joint pain and back pain. Traditional treatments such as icing and opioids only provided temporary and marginal relief.

Vinny started using SPORT Painshield™ and has reported remarkable results. After a few days of treatment, he reported his knee pain went from a 7 to a 3 on the VAS pain scale and his back pain went from a 6 to a 0 on the VAS pain scale. Vinny recommends Painshield™ to anyone who is suffering from joint and back pain. Click on the link to watch the interview with Vinny Testaverde: https://www.youtube.com/watch?v=2latZGP0fck

SPORT Painshield™ was recently exhibited at the National Trainers Association meeting in Baltimore. It was well received by over 7000 sports trainers who attended which resulted in direct sales and potential partnerships.

SPORT PainShield™ generates and delivers localized, low frequency, targeted "slow release" therapeutic ultrasound through a self-adhering patch, placed next to the treated area, for a period of up to 6.5 hours.

Product usage has shown wide range of applications including:

SPORT PainShield™ may be used immediately post-injury and post-op. The product is patch based and does not require medical personnel to apply it and hold it in place while receiving therapy. Patient benefits include its ease of application and use, faster recovery time, high compliance, safety, and effectiveness. SPORT PainShield™ has received CE Mark and FDA clearance.

About NanoVibronix NanoVibronix Inc. is a medical device company headquartered in Elmsford, NY with research and development in Nesher, Israel, that is focused on developing medical devices utilizing its proprietary and patented surface acoustic wave ultrasound. The company's groundbreaking technology allows for the creation of low-frequency ultrasound waves that can be utilized for a variety of medical applications. The devices accelerate wound healing and provide pain relief. The devices can also be administered at home, without the assistance of medical professionals. The company's products include PainShield® and WoundShield™, which both have CE Mark. The PainShield™ also has FDA clearance. NanoVibronix's catheter based products include the UroShield™ and NG-Shield™ that are both CE Marked. Uroshield reduces pain and prevents infection in urinary catheters. Additional information about the company is available at: www.nanovibronix.com.

SAFE HARBOR STATEMENT: This release contains certain statements that are, or may be deemed to be, forward-looking statements within the meaning of section 27A of the Securities Act of 1933 and section 21E of the Securities Exchange Act of 1934, and are made in reliance upon the protections provided by such Acts for forward-looking statements. We have identified forward-looking statements by using words such as "expect," "believe," and "should." Although we believe our expectations are reasonable, our operations involve a number of risks and uncertainties that are beyond our control, and these statements may turn out not to be true. Risk factors associated with our business, including some of the facts set forth herein, are detailed in the Company's Form SEC filings.

 Top of page

 
Ask Us!